Attached files
| file | filename |
|---|---|
| 8-K - 8-K - AGILENT TECHNOLOGIES, INC. | form8-kxq313pressrelease.htm |
Exhibit 99.1
EDITORIAL CONTACT:
Amy Flores
+1 408 345 8194
amy_flores@agilent.com
INVESTOR CONTACT:
Alicia Rodriguez
+1 408 345 8948
alicia_rodriguez@agilent.com
Agilent Technologies Reports Third-Quarter 2013 Results
Highlights:
• | GAAP net income of $168 million, or $0.49 per share |
• | Non-GAAP net income of $233 million, or $0.68 per share(1) |
• | Orders of $1.60 billion and revenues of $1.65 billion |
• | Fourth-quarter fiscal year 2013 revenue guidance of $1.7 billion to $1.72 billion, and non-GAAP earnings guidance of $0.75 to $0.77 per share(2) |
• | Fiscal year 2013 revenue guidance of $6.76 billion to $6.78 billion. Non-GAAP earnings guidance at $2.83 to $2.85 per share(2) |
SANTA CLARA, Calif., Aug. 14, 2013 - Agilent Technologies Inc. (NYSE: A) today reported orders of $1.60 billion, down 4 percent compared with one year ago, and revenues of $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago. Third-quarter GAAP net income was $168 million, or $0.49 per share. Last year's third-quarter GAAP net income was $243 million, or $0.69 per share.
During the third quarter, Agilent had intangible amortization of $48 million and integration and transformation costs of $14 million. Excluding these items and $3 million of other net charges, Agilent reported third-quarter adjusted net income of $233 million, or $0.68 per share(1).
Agilent CEO Bill Sullivan said, “Although we are operating in a very challenging economic environment, we are pleased with our operational performance, as we continue to make progress improving our manufacturing efficiency and streamlining our expense structure. The result has been better than forecasted operating margins.”
Electronic Measurement third-quarter revenues were down 17 percent compared with the prior year, with continuing weakness in wireless manufacturing. Operating margins were 18 percent.
1
Chemical Analysis revenues were up 1 percent compared with a year ago, led by growth in food and energy markets. Operating margins were 22 percent.
Life Sciences revenues were up 3 percent over a year ago, with strength in pharmaceutical end-markets. Operating margins were 17 percent.
Diagnostics and Genomics revenues grew 54 percent, up 6 percent adjusting for the effects of the Dako acquisition. Operating margins were 15 percent.
Agilent generated $215 million of cash from operations in the quarter. Third-quarter ROIC was 15 percent(3).
Fourth-quarter 2013 revenues are expected to be in the range of $1.7 billion to $1.72 billion. Fourth-quarter non-GAAP earnings are expected to be in the range of $0.75 to $0.77 per share(2).
For the full fiscal year 2013, Agilent expects revenue of $6.76 billion to $6. 78 billion and non-GAAP earnings of $2.83 to $2.85 per share(2).
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,500 employees serve customers in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal 2012. Information about Agilent is available at www.agilent.com.
Agilent's management will present more details about its third-quarter FY2013 financial results on a conference call with investors today at 1:30 p.m. PDT. This event will be webcast live in listen-only mode. Listeners may log on at www.investor.agilent.com and select “Q3 2013 Agilent Technologies Inc. Earnings Conference Call” in the “News & Events Calendar of Events” section. The webcast will remain available on the company's website for 90 days.
Additional information regarding financial results can be found at www.investor.agilent.com by selecting “Financial Results” in the “Financial Information” section.
A telephone replay of the conference call will be available at 4:30 p.m. (Pacific Time) after the call through Aug. 21. The replay number is: (888) 286-8010, or for international, dial (617) 801-6888; enter passcode 87350915.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent's future revenues, earnings and profitability; the future demand for the company's products and services; customer expectations; and revenue and non-GAAP earnings guidance for the fourth quarter and full fiscal year 2013. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of our customers' businesses; unforeseen changes in the demand for
2
current and new products, technologies, and services; customer purchasing decisions and timing, and the risk that we are not able to realize the savings expected from integration and restructuring activities.
In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on our operations, our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of our supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the quarter ended April 30, 2013. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.
(1) Non-GAAP net income and non-GAAP net income per share exclude primarily the impacts of acquisition and integration costs, transformation initiatives and restructuring costs, and non-cash intangibles amortization. We also exclude any tax benefits that are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. A reconciliation between non-GAAP net income and GAAP net income is set forth on page 6 of the attached tables along with additional information regarding the use of this non-GAAP measure.
(2) Non-GAAP earnings per share as projected for Q4FY13 and full fiscal year 2013 excludes primarily the impacts of acquisition and integration costs, future restructuring costs, asset impairment charges, and non-cash intangibles amortization. We also exclude any tax benefits that are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $50 million per quarter.
(3) Return on invested capital (ROIC) is a non-GAAP measure and is defined as income from operations less other (income) expense and taxes, annualized, divided by the average of the two most recent quarter-end balances of assets less net current liabilities. The reconciliation of ROIC can be found on page 8 of the attached tables, along with additional information regarding the use of this non-GAAP measure.
# # #
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.
3
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Three Months Ended | ||||||||||
July 31, | Percent | |||||||||
2013 | 2012 | Inc/(Dec) | ||||||||
Orders | $ | 1,600 | $ | 1,662 | (4)% | |||||
Net revenue | $ | 1,652 | $ | 1,723 | (4)% | |||||
Costs and expenses: | ||||||||||
Cost of products and services | 796 | 833 | (4)% | |||||||
Research and development | 171 | 162 | 6% | |||||||
Selling, general and administrative | 449 | 458 | (2)% | |||||||
Total costs and expenses | 1,416 | 1,453 | (3)% | |||||||
Income from operations | 236 | 270 | (13)% | |||||||
Interest income | 2 | 2 | — | |||||||
Interest expense | (27 | ) | (24 | ) | 13% | |||||
Other income (expense), net | 1 | (10 | ) | (110)% | ||||||
Income before taxes | 212 | 238 | (11)% | |||||||
Provision (benefit) for income taxes | 44 | (5 | ) | (980)% | ||||||
Net income | $ | 168 | $ | 243 | (31)% | |||||
Net income per share: | ||||||||||
Basic | $ | 0.50 | $ | 0.70 | ||||||
Diluted | $ | 0.49 | $ | 0.69 | ||||||
Weighted average shares used in computing net income per share: | ||||||||||
Basic | 339 | 348 | ||||||||
Diluted | 343 | 353 | ||||||||
Cash dividends declared per common share | $ | 0.12 | $ | 0.10 | ||||||
The preliminary income statement is estimated based on our current information.
1
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Nine Months Ended | ||||||||||
July 31, | Percent | |||||||||
2013 | 2012 | Inc/(Dec) | ||||||||
Orders | $ | 4,998 | $ | 5,126 | (2)% | |||||
Net revenue | $ | 5,064 | $ | 5,091 | (1)% | |||||
Costs and expenses: | ||||||||||
Cost of products and services | 2,437 | 2,409 | 1% | |||||||
Research and development | 531 | 490 | 8% | |||||||
Selling, general and administrative | 1,430 | 1,351 | 6% | |||||||
Total costs and expenses | 4,398 | 4,250 | 3% | |||||||
Income from operations | 666 | 841 | (21)% | |||||||
Interest income | 5 | 7 | (29)% | |||||||
Interest expense | (77 | ) | (75 | ) | 3% | |||||
Other income (expense), net | 11 | 14 | (21)% | |||||||
Income before taxes | 605 | 787 | (23)% | |||||||
Provision for income taxes | 92 | 59 | 56% | |||||||
Net income | $ | 513 | $ | 728 | (30)% | |||||
Net income per share: | ||||||||||
Basic | $ | 1.49 | $ | 2.09 | ||||||
Diluted | $ | 1.47 | $ | 2.06 | ||||||
Weighted average shares used in computing net income per share: | ||||||||||
Basic | 344 | 348 | ||||||||
Diluted | 348 | 353 | ||||||||
Cash dividends declared per common share | $ | 0.34 | $ | 0.20 | ||||||
The preliminary income statement is estimated based on our current information.
2
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(In millions)
(Unaudited)
PRELIMINARY
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, | July 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(in millions) | ||||||||||||||||
Net Income | $ | 168 | $ | 243 | $ | 513 | $ | 728 | ||||||||
Other comprehensive income (loss), net of tax: | ||||||||||||||||
Change in unrealized gain on investments | 4 | — | 5 | 6 | ||||||||||||
Change in unrealized gain on derivative instruments | (4 | ) | (2 | ) | 7 | 2 | ||||||||||
Amounts reclassified into earnings related to derivative instruments | (3 | ) | — | (8 | ) | (4 | ) | |||||||||
Foreign currency translation | (32 | ) | (102 | ) | (87 | ) | (160 | ) | ||||||||
Net defined benefit pension cost and post retirement plan costs: | ||||||||||||||||
Change in actuarial net loss | 15 | 13 | 45 | 41 | ||||||||||||
Change in net prior service benefit | (8 | ) | (12 | ) | (24 | ) | (36 | ) | ||||||||
Other comprehensive loss | (28 | ) | (103 | ) | (62 | ) | (151 | ) | ||||||||
Total comprehensive income | $ | 140 | $ | 140 | $ | 451 | $ | 577 | ||||||||
The preliminary statement of comprehensive income is estimated based on our current information.
3
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEET
(In millions, except par value and share amounts)
(Unaudited)
PRELIMINARY
July 31, 2013 | October 31, 2012 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 2,330 | $ | 2,351 | ||||
Accounts receivable, net | 875 | 923 | ||||||
Inventory | 1,054 | 1,014 | ||||||
Other current assets | 325 | 341 | ||||||
Total current assets | 4,584 | 4,629 | ||||||
Property, plant and equipment, net | 1,139 | 1,164 | ||||||
Goodwill | 2,995 | 3,025 | ||||||
Other intangible assets, net | 945 | 1,086 | ||||||
Long-term investments | 124 | 109 | ||||||
Other assets | 491 | 523 | ||||||
Total assets | $ | 10,278 | $ | 10,536 | ||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 407 | $ | 461 | ||||
Employee compensation and benefits | 345 | 387 | ||||||
Deferred revenue | 463 | 420 | ||||||
Short-term debt | — | 250 | ||||||
Other accrued liabilities | 335 | 375 | ||||||
Total current liabilities | 1,550 | 1,893 | ||||||
Long-term debt | 2,701 | 2,112 | ||||||
Retirement and post-retirement benefits | 463 | 554 | ||||||
Other long-term liabilities | 774 | 792 | ||||||
Total liabilities | 5,488 | 5,351 | ||||||
Total Equity: | ||||||||
Stockholders' equity: | ||||||||
Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding | — | — | ||||||
Common stock; $0.01 par value; 2 billion shares authorized; 600 million shares at July 31, 2013 and 595 million shares at October 31, 2012, issued | 6 | 6 | ||||||
Treasury stock at cost; 269 million shares at July 31, 2013 and 249 million shares at October 31, 2012 | (9,607 | ) | (8,707 | ) | ||||
Additional paid-in-capital | 8,660 | 8,489 | ||||||
Retained earnings | 5,901 | 5,505 | ||||||
Accumulated other comprehensive loss | (173 | ) | (111 | ) | ||||
Total stockholders' equity | 4,787 | 5,182 | ||||||
Non-controlling interest | 3 | 3 | ||||||
Total equity | 4,790 | 5,185 | ||||||
Total liabilities and equity | $ | 10,278 | $ | 10,536 | ||||
The preliminary balance sheet is estimated based on our current information.
4
AGILENT TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(In millions)
(Unaudited)
PRELIMINARY
Three Months Ended | Nine Months Ended | |||||||
July 31, | July 31, | |||||||
2013 | 2013 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 168 | $ | 513 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 91 | 277 | ||||||
Share-based compensation | 17 | 66 | ||||||
Excess tax benefit from share-based plans | — | (2 | ) | |||||
Excess and obsolete inventory and inventory related charges | 14 | 36 | ||||||
Other non-cash expenses, net | 3 | 8 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable | 34 | 31 | ||||||
Inventory | (28 | ) | (81 | ) | ||||
Accounts payable | (40 | ) | (47 | ) | ||||
Employee compensation and benefits | (36 | ) | (37 | ) | ||||
Other assets and liabilities | (8 | ) | 11 | |||||
Net cash provided by operating activities (a) | 215 | 775 | ||||||
Cash flows from investing activities: | ||||||||
Investments in property, plant and equipment | (53 | ) | (163 | ) | ||||
Proceeds from sale of property, plant and equipment | — | 2 | ||||||
Purchase of other investments | — | (15 | ) | |||||
Payment to acquire equity method investment | — | (21 | ) | |||||
Proceeds from sale of investment securities | — | 11 | ||||||
Acquisition of businesses and intangible assets, net of cash acquired | (1 | ) | (11 | ) | ||||
Net cash used in investing activities | (54 | ) | (197 | ) | ||||
Cash flows from financing activities: | ||||||||
Issuance of common stock under employee stock plans | 48 | 116 | ||||||
Treasury stock repurchases | (681 | ) | (900 | ) | ||||
Payment of dividends | (41 | ) | (117 | ) | ||||
Issuance of senior notes | 597 | 597 | ||||||
Debt issuance cost | (5 | ) | (5 | ) | ||||
Repayment of senior notes | (250 | ) | (250 | ) | ||||
Payments to prior non-controlling interest | — | (3 | ) | |||||
Excess tax benefit from share-based plans | — | 2 | ||||||
Net cash used in financing activities | (332 | ) | (560 | ) | ||||
Effect of exchange rate movements | (18 | ) | (39 | ) | ||||
Net decrease in cash and cash equivalents | (189 | ) | (21 | ) | ||||
Cash and cash equivalents at beginning of period | 2,519 | 2,351 | ||||||
Cash and cash equivalents at end of period | $ | 2,330 | $ | 2,330 | ||||
(a) Cash payments included in operating activities: | ||||||||
Restructuring payments | 15 | 26 | ||||||
Income tax payments, net | 39 | 93 | ||||||
The preliminary cash flow is estimated based on our current information.
5
AGILENT TECHNOLOGIES, INC.
NON-GAAP NET INCOME AND DILUTED EPS RECONCILIATIONS
(In millions, except per share amounts)
(Unaudited)
PRELIMINARY
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||
July 31, | July 31, | |||||||||||||||||||||||||||||||
2013 | Diluted EPS | 2012 | Diluted EPS | 2013 | Diluted EPS | 2012 | Diluted EPS | |||||||||||||||||||||||||
GAAP Net income | $ | 168 | $ | 0.49 | $ | 243 | $ | 0.69 | $ | 513 | $ | 1.47 | $ | 728 | $ | 2.06 | ||||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||||||||||||||
Restructuring and other related costs | 1 | — | — | — | 56 | 0.16 | — | — | ||||||||||||||||||||||||
Asset impairments and write-downs | 1 | — | 15 | 0.04 | 3 | 0.01 | 15 | 0.04 | ||||||||||||||||||||||||
Intangible amortization | 48 | 0.14 | 32 | 0.09 | 151 | 0.43 | 85 | 0.24 | ||||||||||||||||||||||||
Transformational initiatives | 8 | 0.02 | 3 | 0.01 | 14 | 0.04 | 19 | 0.05 | ||||||||||||||||||||||||
Acquisition and integration costs | 6 | 0.02 | 41 | 0.12 | 22 | 0.06 | 54 | 0.15 | ||||||||||||||||||||||||
Other | 2 | 0.01 | 2 | 0.01 | 11 | 0.03 | (11 | ) | (0.03 | ) | ||||||||||||||||||||||
Adjustment for taxes (a) | (1 | ) | — | (58 | ) | (0.17 | ) | (46 | ) | (0.12 | ) | (93 | ) | (0.25 | ) | |||||||||||||||||
Non-GAAP Net Income | $ | 233 | $ | 0.68 | $ | 278 | $ | 0.79 | $ | 724 | $ | 2.08 | $ | 797 | $ | 2.26 | ||||||||||||||||
(a) The adjustment for taxes excludes tax benefits that management believes are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. For the three and nine months ended July 31, 2013, management uses a non-GAAP effective tax rate of 16%, respectively, that we believe to be indicative of on-going operations.
Historical amounts are reclassified to conform with current period presentation.
We provide non-GAAP net income and non-GAAP net income per share amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to the amortization of intangibles, the impact of restructuring charges and acquisition and integration costs. Some of the exclusions, such as impairments, may be beyond the control of management. Further, some may be less predictable than revenue derived from our core businesses (the day to day business of selling our products and services). These reasons provide the basis for management's belief that the measures are useful.
Our management uses non-GAAP measures to evaluate the performance of our core businesses, to estimate future core performance and to compensate employees. Since management finds this measure to be useful, we believe that our investors benefit from seeing our results "through the eyes" of management in addition to seeing our GAAP results. This information facilitates our management's internal comparisons to our historical operating results as well as to the operating results of our competitors.
Our management recognizes that items such as amortization of intangibles and restructuring charges can have a material impact on our cash flows and/or our net income. Our GAAP financial statements including our statement of cash flows portray those effects. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. To gain a complete picture of all effects on the company's profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company's performance.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information.
6
AGILENT TECHNOLOGIES, INC.
SEGMENT INFORMATION
(In millions, except where noted)
(Unaudited)
PRELIMINARY
Life Sciences
Q3'13 | Q3'12 | Q2'13 | ||||||||||
Orders | $ | 376 | $ | 373 | $ | 416 | ||||||
Revenues | $ | 401 | $ | 391 | $ | 405 | ||||||
Gross Margin, % | 51 | % | 51 | % | 51 | % | ||||||
Income from Operations | $ | 67 | $ | 57 | $ | 61 | ||||||
Segment Assets | $ | 1,381 | $ | 1,462 | $ | 1,402 | ||||||
Return On Invested Capital (a) , % | 21 | % | 17 | % | 20 | % | ||||||
Chemical Analysis
Q3'13 | Q3'12 | Q2'13 | ||||||||||
Orders | $ | 390 | $ | 372 | $ | 408 | ||||||
Revenues | $ | 387 | $ | 381 | $ | 401 | ||||||
Gross Margin, % | 51 | % | 50 | % | 51 | % | ||||||
Income from Operations | $ | 83 | $ | 80 | $ | 89 | ||||||
Segment Assets | $ | 1,732 | $ | 1,739 | $ | 1,739 | ||||||
Return On Invested Capital (a) , % | 19 | % | 18 | % | 20 | % | ||||||
Electronic Measurement
Q3'13 | Q3'12 | Q2'13 | ||||||||||
Orders | $ | 674 | $ | 811 | $ | 701 | ||||||
Revenues | $ | 701 | $ | 845 | $ | 760 | ||||||
Gross Margin, % | 57 | % | 56 | % | 57 | % | ||||||
Income from Operations | $ | 129 | $ | 197 | $ | 156 | ||||||
Segment Assets | $ | 2,008 | $ | 2,184 | $ | 2,019 | ||||||
Return On Invested Capital (a) , % | 30 | % | 43 | % | 38 | % | ||||||
Diagnostics and Genomics
Q3'13 | Q3'12 | Q2'13 | ||||||||||
Orders | $ | 160 | $ | 106 | $ | 163 | ||||||
Revenues | $ | 163 | $ | 106 | $ | 166 | ||||||
Gross Margin, % | 59 | % | 61 | % | 63 | % | ||||||
Income from Operations | $ | 24 | $ | 16 | $ | 28 | ||||||
Segment Assets | $ | 2,871 | $ | 2,645 | $ | 2,854 | ||||||
Return On Invested Capital (a) , % | 3 | % | 2 | % | 3 | % | ||||||
Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to the amortization of intangibles, the impact of restructuring charges, acquisition and integration costs.
In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.
(a) Return On Invested Capital is a non-GAAP measure and is defined as income from operations less other (income) expense and taxes, annualized, divided by the average of the two most recent quarter-end balances of assets less net current liabilities. The reconciliation of ROIC can be found on page 8 of these tables, along with additional information regarding the use of this non-GAAP measure.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
The preliminary segment information is estimated based on our current information.
7
AGILENT TECHNOLOGIES, INC.
RECONCILIATION OF ROIC
(In millions)
(Unaudited)
PRELIMINARY
LSG | CAG | EMG | DGG | Agilent | LSG | CAG | EMG | DGG | Agilent | LSG | CAG | EMG | DGG | |||||||||||||||||||||||||||||||
Q3'13 | Q3'13 | Q3'13 | Q3'13 | Q3'13 | Q3'12 | Q3'12 | Q3'12 | Q3'12 | Q3'12 | Q2'13 | Q2'13 | Q2'13 | Q2'13 | |||||||||||||||||||||||||||||||
Numerator: | ||||||||||||||||||||||||||||||||||||||||||||
Non-GAAP income from operations | $ | 67 | $ | 83 | $ | 129 | $ | 24 | $ | 303 | $ | 57 | $ | 80 | $ | 197 | $ | 16 | $ | 350 | $ | 61 | $ | 89 | $ | 156 | $ | 28 | ||||||||||||||||
Less: | ||||||||||||||||||||||||||||||||||||||||||||
Taxes and Other (income)/expense | 11 | 13 | 20 | 6 | 49 | 8 | 12 | 30 | 3 | 53 | 8 | 13 | 22 | 4 | ||||||||||||||||||||||||||||||
Segment return | 56 | 70 | 109 | 18 | 254 | (a) | 49 | 68 | 167 | 13 | 297 | (a) | 53 | 76 | 134 | 24 | ||||||||||||||||||||||||||||
Segment return annualized | $ | 224 | $ | 280 | $ | 436 | $ | 72 | $ | 1,016 | $ | 196 | $ | 272 | $ | 668 | $ | 52 | $ | 1,188 | $ | 212 | $ | 304 | $ | 536 | $ | 96 | ||||||||||||||||
Denominator: | ||||||||||||||||||||||||||||||||||||||||||||
Segment assets (b) | $ | 1,381 | $ | 1,732 | $ | 2,008 | $ | 2,871 | $ | 7,994 | $ | 1,462 | $ | 1,739 | $ | 2,184 | $ | 2,645 | $ | 8,032 | $ | 1,402 | $ | 1,739 | $ | 2,019 | $ | 2,854 | ||||||||||||||||
Less: | ||||||||||||||||||||||||||||||||||||||||||||
Net current liabilities (c) | 308 | 235 | 522 | 102 | 1,167 | 299 | 235 | 600 | 77 | 1,219 | 329 | 253 | 572 | 96 | ||||||||||||||||||||||||||||||
Invested capital | $ | 1,073 | $ | 1,497 | $ | 1,486 | $ | 2,769 | $ | 6,827 | $ | 1,163 | $ | 1,504 | $ | 1,584 | $ | 2,568 | $ | 6,813 | $ | 1,073 | $ | 1,486 | $ | 1,447 | $ | 2,758 | ||||||||||||||||
Average invested capital | $ | 1,073 | $ | 1,491 | $ | 1,467 | $ | 2,763 | $ | 6,796 | $ | 1,149 | $ | 1,488 | $ | 1,555 | $ | 2,551 | $ | 6,741 | $ | 1,081 | $ | 1,484 | $ | 1,430 | $ | 2,753 | ||||||||||||||||
ROIC | 21 | % | 19 | % | 30 | % | 3 | % | 15 | % | 17 | % | 18 | % | 43 | % | 2 | % | 18 | % | 20 | % | 20 | % | 38 | % | 3 | % | ||||||||||||||||
.
ROIC calculation:(annualized current quarter segment return)/(average of the two most recent quarter-end balances of Segment Invested Capital)
(a) Agilent return is equal to non-GAAP net income of $233 million plus net interest expense after tax of $21 million for Q3'13, and $278 million plus net interest expense after tax of $19 million for Q3'12. Please see "Non-GAAP Net Income and Diluted EPS Reconciliations" for a reconciliation of non-GAAP net income to GAAP net income.
(b) Segment assets consist of inventory, accounts receivable, property plant and equipment, gross goodwill and other intangibles, deferred taxes and allocated corporate assets.
(c) Includes accounts payable, employee compensation and benefits, deferred revenue, certain other accrued liabilities and allocated corporate liabilities.
Return on Invested Capital (ROIC) is a non-GAAP measure that management believes provides useful supplemental information for management and the investor. ROIC is a tool by which we track how much value we are creating for our shareholders. Management uses ROIC as a performance measure for our businesses, and our senior managers' compensation is linked to ROIC improvements as well as other performance criteria. We believe that ROIC provides our management with a means to analyze and improve their business, measuring segment profitability in relation to net asset investments. We acknowledge that ROIC may not be calculated the same way by every company. When we complete major acquisitions, we may adjust invested capital for the relevant segment in the quarter when the acquisition occurred. We compensate for this limitation by monitoring and providing to the reader a full GAAP income statement and balance sheet.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
The preliminary reconciliation of ROIC is estimated based on our current information.
8